Search results for " tumour"

showing 10 items of 178 documents

Hematological Malignancies in the Elderly: The Epidemiological Perspective

2014

In the more developed countries the total number of new cases with a hematological tumour was 415,433 for all ages, whilst 188,654 occurred in people aged 70 or more years, representing the 45 % of total cases, equally divided into two sexes. The most these malignancies is closely linked to age and incidence rates increased exponentially after 50 years of age. Aetiology of hematological tumours is largely unknown. However the basic causal mechanism could be a decline in adaptive immunity, strongly related with individual age. In addition to such immunodeficiency, some specific risk factors have been found: viral infections, overweight and obesity (particularly for non-Hodgkin’s lymphomas - …

Pediatricsmedicine.medical_specialtySurvivalbusiness.industryIncidenceIncidence (epidemiology)Perspective (graphical)Hematological tumourDescriptive epidemiologyDescriptive epidemiologyElderlyEpidemiologyTrendmedicineEtiologyAetiologyMortalitybusinessDeveloped countryDemography
researchProduct

Wilms tumours diagnosed by routine physical examinations.

1988

Sir: The prognosis of stage I and -II Wilms tumours with favourable histology is good, reaching 97% (stage I) and 92% (stage II) 5 year disease-free survival rates [1]. With these figures in mind the question arises whether the overall prognosis of Wilms tumours could be improved by presymptomatic routine physical examinations in an attempt to avoid stage III to V primary diagnoses. In the Federal Republic of Germany six routine physical examinations (RPE) are offered to infants, and two additional ones to children between 12 and 48 months. The 1980-1987 German Wilms tumour study [1] listed 313 patients, 29 of whom (9%) were diagnosed by such routine examinations. As shown in Table 1, the R…

Pediatricsmedicine.medical_specialtybusiness.industryWilms tumourFederal republic of germanyInfantStage iiWilms TumorKidney NeoplasmsChild PreschoolPediatrics Perinatology and Child HealthmedicinePhysical therapyHumansStage (cooking)Detection ratebusinessPhysical ExaminationEuropean journal of pediatrics
researchProduct

Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts

2016

Background: Keratin-producing odontogenic cysts (KPOCs) are a group of cystic lesions that are often aggressive, with high rates of recurrence and multifocality. KPOCs included orthokeratinised odontogenic cyst (OOC) and parakeratotic odontogenic cysts, which are now considered true tumours denominated keratocystic odontogenic tumours (KCOTs). GLUT1 is a protein transporter that is involved in the active uptake of glucose across cell membranes and that is overexpressed in tumours in close correlation with the proliferation rate and positron emission tomography (PET) imaging results. Methods: A series of 58 keratin-producing odontogenic cysts was evaluated histologically and immunohistochemi…

Positron emission tomographyPathologymedicine.medical_specialtyKeratocystic odontogenic tumourOdontogenic TumorsOdontologia03 medical and health sciences0302 clinical medicineKeratocystic odontogenic tumourGlucose transporter proteinKeratinmedicineHumansCàncerGeneral Dentistrychemistry.chemical_classificationGlucose Transporter Type 1medicine.diagnostic_testbiologyDentistry(all)business.industryKeratin-producing odontogenic cystGlucose transporterCancerEpithelial Cells030206 dentistrymedicine.diseasePatologiaImmunohistochemistryOrthokeratinised odontogenic cystchemistryPositron emission tomography030220 oncology & carcinogenesisOdontogenic Cystsbiology.proteinKeratinsImmunohistochemistryGLUT1businessGlucose Transporter Type 1Research ArticleBMC Oral Health
researchProduct

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours

2019

BACKGROUND: Interferon-induced expression of programmed cell death ligands (PD-L1/PD-L2) may sustain tumour immuneevasion. Patients featuring MET amplification, a genetic lesion driving transformation, may benefit from anti-MET treatment. We explored if MET-targeted therapy interferes with Interferon-gamma modulation of PD-L1/PD-L2 in MET-amplified tumours.METHODS: PD-L1/PD-L2 expression and signalling pathways downstream of MET or Interferon-gamma were analysed in MET-amplified tumour cell lines and in patient-derived tumour organoids, in basal condition, upon Interferon-gamma stimulation, and after anti-MET therapy.RESULTS: PD-L1 and PD-L2 were upregulated in MET-amplified tumour cells up…

Programmed cell deathCancer ResearchCancer immunotherapyMET-amplified tumoursB7-H1 AntigenArticleInterferon-gammaTargeted therapiesDownregulation and upregulationInterferonCell Line TumorNeoplasmsHumansMedicineMet inhibitionMolecular Targeted TherapySTAT1Kinase activityReceptorProtein Kinase InhibitorsJanus KinasesReceptors InterferonOncogenebiologyPD-1 ligandsbusiness.industryLiver NeoplasmsOncogenesProto-Oncogene Proteins c-metProgrammed Cell Death 1 Ligand 2 ProteinOrganoidsSTAT1 Transcription FactorOncologybiology.proteinCancer researchOncology; Cancer Research; Met inhibition; IFNγ-induction;PD-1 ligands; MET-amplified tumoursTumor EscapeSignal transductionColorectal NeoplasmsbusinessIFNγ-inductionSignal Transductionmedicine.drug
researchProduct

A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches.

2014

OBJECTIVES: The aim of the present paper was to conduct a comparative analysis of outcomes after thoracoscopic resection versus standard thoracotomy approach in the treatment of Pancoast tumours. METHODS: All consecutive patients with Pancoast tumours undergoing surgical treatment from March 2000 to November 2012 were enrolled. Patients were divided into 2 groups according to whether a thoracoscopic or standard thoracotomy approach was adopted. In addition to morbidity and mortality, (i) intensity of pain; (ii) respiratory function focusing on the postoperative value and its variation with respect to the predicted value (Delta); (iii) analgesic consumption at different times during the post…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyVital capacityTime Factorsmedicine.medical_treatmentSettore MED/21 - Chirurgia ToracicaKaplan-Meier EstimatePreoperative carePancoast tumour; Superior sulcus tumour; Video-assisted thoracoscopic resection; Surgery; ThoracotomyPancoast tumorRisk FactorsmedicineHumansRespiratory functionNeoplasm InvasivenessThoracotomyLung cancerPneumonectomySurvival rateAgedNeoplasm StagingPain MeasurementRetrospective StudiesAnalgesicsPain Postoperativebusiness.industryThoracic Surgery Video-AssistedSuperior sulcus tumourPancoast SyndromeRecovery of FunctionPleural cavityMiddle Agedmedicine.diseaseSurgerySettore MED/18 - Chirurgia Generalemedicine.anatomical_structureTreatment OutcomeItalyThoracotomyAnesthesiaPancoast tumourVideo-assisted thoracoscopic resectionSurgeryFemaleLung cancerCardiology and Cardiovascular MedicinebusinessInteractive cardiovascular and thoracic surgery
researchProduct

Corrigendum to: A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches (In…

2015

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryPancoast tumourSettore MED/21 - Chirurgia ToracicaMEDLINE030204 cardiovascular system & hematologyResectionSurgery03 medical and health sciencesSettore MED/18 - Chirurgia Generale0302 clinical medicineText mining030228 respiratory systemVideo assisted thoracic surgeryMedicineSurgerybusinessCardiology and Cardiovascular Medicine
researchProduct

La termoablazione nel trattamento delle neoplasie epatiche primitive e secondarie

2004

Radiofrequency thermoablation is a locoregional procedure based on the use of electromagnetic waves that induce movement and consequently the production of heat. This is the basis for the coagulative necrosis produced in the tissues. The method, experimented with and developed in the '90s, is today extensively used in the treatment of focal hepatic lesions, both primary and secondary. The factors that condition the procedure are related essentially to the characteristics of the tumours and to the possibility of obtaining a predictable area of necrosis that guarantees the radicality of the treatment. As regards primary neoplasms, it should be stressed that the treatment for hepatocellular ca…

Radiofrequency thermoablation primary secondary liver tumours
researchProduct

Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

2021

The combination of trastuzumab plus pertuzumab plus docetaxel as a first-line therapy in patients with HER2-positive metastatic breast cancer has provided significant clinical benefits compared to trastuzumab plus docetaxel alone. However, despite the therapeutic success of existing therapies targeting HER2, tumours invariably relapse. Therefore, there is an urgent need to improve our understanding of the mechanisms governing resistance, so that specific therapeutic strategies can be developed to provide improved efficacy. It is well known that the tumour microenvironment (TME) has a significant impact on cancer behaviour. Cancer-associated fibroblasts (CAFs) are essential components of the…

Receptor ErbB-2Cancer-associated fibroblastQH301-705.5breast cancer; HER2-positive; tumour microenvironment; targeted therapy; trastuzumab; resistance; cancer-associated fibroblast; label-free proteomics; miRNABreast NeoplasmsDocetaxelAntibodies Monoclonal HumanizedArticleCatalysisInorganic ChemistryresistanceDrug Delivery SystemsLabel-free proteomicsbreast cancerCancer-Associated FibroblastsCell Line TumorAntineoplastic Combined Chemotherapy ProtocolsHumansPhysical and Theoretical ChemistryBiology (General)skin and connective tissue diseasesMolecular BiologyQD1-999SpectroscopymiRNAOrganic ChemistryGeneral Medicinetargeted therapyHER2-positiveComputer Science ApplicationstrastuzumabChemistryDrug Resistance NeoplasmFemaletumour microenvironmentInternational Journal of Molecular Sciences
researchProduct

Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices …

2019

Abstract Background Cutaneous angiosarcoma (cAS) is a highly aggressive malignancy that challenges the radicality of surgical treatment. Electrochemotherapy (ECT), a skin-directed treatment based on cytotoxic chemotherapy combined with local electric pulses, may be an intraoperative adjunct and a new opportunity in the therapeutic strategy. This cohort study reports the experience with ECT as an option. Methods Data on patients with locally-advanced/metastatic cAS who underwent ECT between October 2013 and October 2018 at eight European centres were prospectively submitted to the InspECT (International network for sharing practices of ECT) register. Patients received therapy according to th…

Register basedmedicine.medical_specialtyElectrochemotherapySkin NeoplasmsElectrochemotherapyHemangiosarcomaSkin metastasesTumour controlPainKaplan-Meier EstimateMalignancyCutaneous angiosarcomaCohort Studies03 medical and health sciencesBleomycin0302 clinical medicineAntibioticsSkin Ulcermedicine80 and overHumansAngiosarcomaCutaneous angiosarcoma; Electrochemotherapy; Skin metastases; Skin-directed therapies; Tumour control; Aged; Aged 80 and over; Antibiotics Antineoplastic; Bleomycin; Cohort Studies; Electrochemotherapy; Feasibility Studies; Female; Hemangiosarcoma; Humans; Kaplan-Meier Estimate; Middle Aged; Pain; Patient Reported Outcome Measures; Prospective Studies; Registries; Skin Neoplasms; Skin Ulcer; Treatment OutcomePatient Reported Outcome MeasuresProspective StudiesRegistriesSkin-directed therapiesAgedAged 80 and overInternational networkAntibiotics Antineoplasticbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseAntineoplasticmedicine.anatomical_structureTreatment OutcomeTolerability030220 oncology & carcinogenesisScalpFeasibility Studies030211 gastroenterology & hepatologySurgeryFemaleRadiologybusinessCohort studyInternational journal of surgery (London, England)
researchProduct

Transsacral rectocele following combined neurinoma resection: A case report

2015

Highlights • Case of a combined (transsacral and laparoscopic) resection of a presacral tumour. • First described case of a transsacral rectocele two years after this procedure. • Possibility of laparoscopic defect repair of transsacral defects.

S3/4 sacral segmentmedicine.medical_specialtyDefect repairPresacral tumourmedicine.diagnostic_testbusiness.industryTumor resectionTranssacral rectoceleAbdominotranssacral tumour resectionCase ReportMagnetic resonance imaging030230 surgeryLaparoscopic mesh graft implantationResectionSurgeryBMI body-mass-index03 medical and health sciences0302 clinical medicineText mining030220 oncology & carcinogenesisMedicineSurgerybusinessMRI magnetic resonance imagingSacral segmentInternational Journal of Surgery Case Reports
researchProduct